12th European Executive Congress on Clinical & Translational Medicine
EECCTM 2027 convenes senior clinical, translational, academic and industry leaders to accelerate the pathway from discovery to patient impact—through curated participation, focused sessions, and outcome-driven collaboration.
Austria
3-day executive program
Curated access to protect relevance and trust.
Evidence, partnerships, and implementable next steps.
A premium executive format built for high-trust discussion, curated introductions, and collaboration outcomes. Apply for eligibility review and secure participation once confirmed.
Why senior leaders choose this format
A focused executive cadence for clinical and translational decision-making — aligning evidence, real-world data, implementation pathways, and cross-sector partnerships.
Relevance-first attendance to protect executive time and trust.
Facilitated discussions that produce next-step decisions.
Introductions aligned to trials, RWE, implementation, and partnerships.
Invoices, documentation, and delegate assistance.
Who should attend
Designed for decision-makers driving clinical translation, evidence strategy, and implementation.
What you will gain
Clear outcomes—kept intentionally concise to avoid noise.
Closed-door discussion with senior leaders on evidence-to-impact decisions.
Curated introductions aligned to trials, RWE, implementation, and collaboration needs.
Practical pathways to move evidence into health systems and patient outcomes.
A cadence built for decisions—roundtables, panels, and action-focused sessions.
Participation model
Simple, transparent steps to keep the room relevant.
Submit your details for eligibility review.
We confirm fit and share next steps.
Invoice support available for organisations.
Featured Leaders
Senior clinical, translational, and industry leaders shaping evidence generation, implementation pathways, and patient impact.
Themes & focus areas
Clear themes help delegates assess relevance quickly and support high-quality proposals aligned to clinical translation and implementation.
Innovations in trial design, endpoints, adaptive protocols, and strengthening evidence for clinical and regulatory decision-making.
Bridging discovery to patient impact using biomarkers, translational strategy, and effective cross-sector collaboration models.
Registries, EHR integration, data quality and analytics that strengthen real-world evidence and support adoption into practice.
Scaling interventions through clinical adoption, service redesign, operational pathways, and measurable outcomes in care delivery.
Compliance readiness, ethical oversight, safety monitoring, and governance approaches that protect patients and strengthen trust.
Collaboration models, funding pathways, evidence packages, and implementation partnerships that move innovation into routine care.
Agenda at a glance
A clear executive cadence across three days — structured time blocks for roundtables, keynotes, and measurable translational outcomes.
Executive opening, trial design decisions, endpoints, and evidence quality.
RWE integration, analytics, adoption pathways, and health system scaling.
Collaboration models, translation metrics, and next-step executive actions.
Venue & access
All host location information is consolidated for clarity — access routes, recommended stays, and local tips.